Medworld Pharmaceuticals Private Limited
About Medworld Pharmaceuticals Private Limited
Data last updated:
Medworld Pharmaceuticals Private Limited is a private limited company based in Thane, Maharashtra, India. It operates in the IT products retail and distribution segment of the technology and IT services sector. It was incorporated on 20 June 2006 and has been in existence for over 20 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24239MH2006PTC162744. Its GSTIN is 27AAECM6839N1ZS (Maharashtra). The company holds 2 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹50 Lakh and a paid-up capital of ₹3.75 Lakh. It is led by directors Ramakrishnan Kannan and Hema Kannan.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 103 A Wing Orion Business Park, Thane, Maharashtra.
As per the financials filed for FY 2025, the company reported a revenue of ₹18.56 Lakh, a decline of 74% compared to the previous year. For the same year it recorded a net loss of ₹19.13 Lakh (net margin -103%) and EBITDA of -₹19.13 Lakh (EBITDA margin -103%). Revenue has declined at a compounded annual rate (CAGR) of 3% over three years and 41% over five years.
As per MCA filings, the company has open charges of ₹3.19 Cr and satisfied charges of ₹9.67 Cr on record.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Medworld Pharmaceuticals Private Limited's registered office is in Thane, Maharashtra. Its e-mail address is in the company report.
- Email
- Registered Address103 A Wing Orion Business Park Chheda Mall, Near Cine Wonder Ghodbunder Road, Thane, Maharashtra, India – 400607
- IndustryInformation Technology, IT Products Retail & Distribution, IT Consulting & Support Services
To see the full contact details of Medworld Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Medworld Pharmaceuticals is trade. In detail, this covers retail trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G2 | Retail Trading |
To see the full business activity and turnover split of Medworld Pharmaceuticals Private Limited, buy the company report.
Financials of Medworld Pharmaceuticals Private Limited
FY 2025 filings availableMedworld Pharmaceuticals Private Limited reported revenue of ₹18.56 Lakh (down 74% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 41% over five years, including a 74% fall in the latest year. EBITDA fell 127% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹19.13 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹19.13 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -103% | ||||
| Net Profit Margin | -103% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Medworld Pharmaceuticals Private Limited, buy the company report.
Board of directors of Medworld Pharmaceuticals Private Limited
Medworld Pharmaceuticals has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ramakrishnan Kannan | Director | 10 Jul 2006 | 20 Years 3 Months | Current |
| Hema Kannan | Director | 20 May 2009 | 17 Years 5 Months | Current |
Auditor
Medworld Pharmaceuticals Private Limited is audited by ANAND MEHTA & ASSOCIATES for the financial year 2020.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| ANAND MEHTA & ASSOCIATES | FY 2020 | 127305W/W100058 |
Shareholding
The shareholding of Medworld Pharmaceuticals Private Limited is on record for 4 financial years, the latest being FY 2020, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2020 | FY 2019 | FY 2017 | FY 2016 |
|---|---|---|---|---|
| Promoters | ||||
| Domestic institutional investors (DII) | ||||
| Foreign institutional investors (FII) | ||||
| Public | ||||
| Others |
To see the full shareholding pattern of Medworld Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 09 Jul 2013 | 10438517 | Hdfc Bank Limited | ₹3.19 Cr | Open | |
| 07 Nov 2019 | 100301066 | Others | ₹1.49 Cr | Satisfied | |
| 12 May 2018 | 100181533 | Others | ₹4.78 Cr | Satisfied | |
| 15 Jun 2011 | 10298099 | Hdfc Bank Limited | ₹1.7 Cr | Satisfied | |
| 31 Mar 2011 | 10287212 | Hdfc Bank Limited | ₹1.7 Cr | Satisfied |
To see the full charge records of Medworld Pharmaceuticals Private Limited, buy the company report.
Total charge records: 5 View all charges
Legal cases
No court or tribunal cases involving Medworld Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Medworld Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Medworld Pharmaceuticals has 2 GST registrations: 1 active and 1 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAECM6839N1ZS | Maharashtra | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Medworld Pharmaceuticals Private Limited, buy the company report.
Recent activity
Medworld Pharmaceuticals Private Limited has 4 board changes on record since 2006: 2 appointments and 2 cessations. The latest: Rupesh Hemendra Shah ceased to be Director on 20 Apr 2011.
4 earlier events are in the company report.
Frequently asked questions
Medworld Pharmaceuticals is an active private limited company based in Thane, Maharashtra, India. The company works in IT products retail and distribution, within the information technology industry. It was incorporated on 20 June 2006 (20+ years old) and is registered under CIN U24239MH2006PTC162744.
Medworld Pharmaceuticals has 2 current directors:
- Ramakrishnan Kannan - Director
- Hema Kannan - Director
The latest financial statements of Medworld Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Medworld Pharmaceuticals is 27AAECM6839N1ZS, registered in Maharashtra. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of Medworld Pharmaceuticals is U24239MH2006PTC162744. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Medworld Pharmaceuticals was incorporated on 20 June 2006, making it 20+ years old. It is registered with the Registrar of Companies, Mumbai.
Rupesh Hemendra Shah ceased to be Director on 20 Apr 2011. Ramakrishnan Kannan ceased to be Additional Director on 30 Sep 2010. Hema Kannan was appointed as Director on 20 May 2009. Medworld Pharmaceuticals has 4 board changes on record in total.
The registered office of Medworld Pharmaceuticals is at 103 A Wing Orion Business Park Chheda Mall, Near Cine Wonder Ghodbunder Road, Thane, Maharashtra, India – 400607.
Medworld Pharmaceuticals operates in the information technology industry, in the IT products retail and distribution segment.
Medworld Pharmaceuticals has open charges of ₹3.19 Cr and satisfied charges of ₹9.67 Cr as per latest MCA filings.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
